BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26153762)

  • 1. Responsive population dynamics and wide seeding into the duodenal lamina propria of transglutaminase-2-specific plasma cells in celiac disease.
    Di Niro R; Snir O; Kaukinen K; Yaari G; Lundin KE; Gupta NT; Kleinstein SH; Cols M; Cerutti A; Mäki M; Shlomchik MJ; Sollid LM
    Mucosal Immunol; 2016 Jan; 9(1):254-64. PubMed ID: 26153762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.
    Di Niro R; Mesin L; Zheng NY; Stamnaes J; Morrissey M; Lee JH; Huang M; Iversen R; du Pré MF; Qiao SW; Lundin KE; Wilson PC; Sollid LM
    Nat Med; 2012 Feb; 18(3):441-5. PubMed ID: 22366952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
    Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
    Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Throughput Single-Cell Analysis of B Cell Receptor Usage among Autoantigen-Specific Plasma Cells in Celiac Disease.
    Roy B; Neumann RS; Snir O; Iversen R; Sandve GK; Lundin KEA; Sollid LM
    J Immunol; 2017 Jul; 199(2):782-791. PubMed ID: 28600290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.
    Hnida K; Stamnaes J; du Pré MF; Mysling S; Jørgensen TJ; Sollid LM; Iversen R
    J Biol Chem; 2016 Dec; 291(49):25542-25552. PubMed ID: 27784785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
    Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
    J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease.
    Chen X; Hnida K; Graewert MA; Andersen JT; Iversen R; Tuukkanen A; Svergun D; Sollid LM
    J Biol Chem; 2015 Aug; 290(35):21365-75. PubMed ID: 26160175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease.
    Iversen R; Roy B; Stamnaes J; Høydahl LS; Hnida K; Neumann RS; Korponay-Szabó IR; Lundin KEA; Sollid LM
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15134-15139. PubMed ID: 31285344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease.
    Maglio M; Ziberna F; Aitoro R; Discepolo V; Lania G; Bassi V; Miele E; Not T; Troncone R; Auricchio R
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28934109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.
    Sankari H; Hietikko M; Kurppa K; Kaukinen K; Mansikka E; Huhtala H; Laurila K; Reunala T; Hervonen K; Salmi T; Lindfors K
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.
    Hietikko M; Koskinen O; Kurppa K; Laurila K; Saavalainen P; Salmi T; Ilus T; Huhtala H; Kaukinen K; Lindfors K
    BMC Immunol; 2018 Dec; 19(1):36. PubMed ID: 30522434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice.
    Kalliokoski S; Piqueras VO; Frías R; Sulic AM; Määttä JA; Kähkönen N; Viiri K; Huhtala H; Pasternack A; Laurila K; Sblattero D; Korponay-Szabó IR; Mäki M; Caja S; Kaukinen K; Lindfors K
    Amino Acids; 2017 Mar; 49(3):529-540. PubMed ID: 27503559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.
    Iversen R; Mysling S; Hnida K; Jørgensen TJ; Sollid LM
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17146-51. PubMed ID: 25404341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
    Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of celiac disease autoreactive gut plasma cells and their corresponding memory compartment in peripheral blood using high-throughput sequencing.
    Snir O; Mesin L; Gidoni M; Lundin KE; Yaari G; Sollid LM
    J Immunol; 2015 Jun; 194(12):5703-12. PubMed ID: 25972486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
    Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
    PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of Celiac Disease in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture.
    Auricchio R; Mandile R; Del Vecchio MR; Scapaticci S; Galatola M; Maglio M; Discepolo V; Miele E; Cielo D; Troncone R; Greco L
    Gastroenterology; 2019 Aug; 157(2):413-420.e3. PubMed ID: 30978358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
    Rauhavirta T; Hietikko M; Salmi T; Lindfors K
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
    Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
    BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.